Supp' BuddySupp' Buddy
Longevity·Comparison

EPA vs DHA: Which Omega-3 Actually Matters for Your Goal?

You probably have a bottle of fish oil somewhere. Maybe in the fridge, maybe in a drawer you forgot about. You grabbed it because someone said omega-3s are good for you.

Supp' Buddy
By the Supp'Buddy Research & Editorial Team
April 14, 2026· 9 min read·Grade A
Hero banner variant 1: SB-2026-0008

Illustration: Supp'Buddy Editorial

Key Takeaways
  • EPA and DHA serve different jobs — heart, mood, and anti-inflammatory research points to EPA; brain structure and cognitive maintenance run on DHA
  • For cardiovascular goals, pure EPA (or EPA-dominant) is the evidenced choice — two landmark trials confirm it; a mixed EPA+DHA trial showed no cardiovascular benefit
  • For brain and cognitive aging, DHA is the structural molecule — most relevant for over-60s and those with low fish intake
  • For inflammation, joints, and exercise recovery, use both — combined EPA+DHA at 2-3g/day for at least 6 weeks
  • Most standard fish oil capsules are dramatically under-dosed — 300-500mg combined vs clinical doses of 1.8-4g; check the label for actual EPA+DHA amounts, not total fish oil weight
Evidence Grade
Grade A

EPA vs DHA: Which Omega-3 Actually Matters for Your Goal?

Pick up your fish oil bottle and flip it over. The front says 2,000 mg fish oil. The small print on the back says 300 mg EPA, 200 mg DHA. That's 500 mg of actual omega-3. The cardiovascular trials that changed prescribing guidelines used 1,800 to 4,000 mg of EPA alone23. Your bottle isn't even close. This article tells you which omega-3 your goal needs, at what dose, and in what form.

Your fish oil is two different molecules

EPA and DHA aren't interchangeable. They do different things in your body.

EPA is the anti-inflammatory one. It competes with omega-6 fats for the same enzymes and pushes your body toward less inflammatory signals11. That's why it dominates heart and mood research.

DHA is the structural one. It makes up the vast majority of omega-3 fatty acids in brain tissue, woven into the membranes of every neuron. Your brain depends on it for signaling and long-term maintenance.

What people say online: "I just grab whatever fish oil is on sale."

What the evidence says: The cheapest bottle might have the right molecule for your goal, or it might not. Cardiovascular trials used pure EPA. Brain studies used DHA. A general blend will do something for inflammation, but if you care about your heart, one trial used a blend of both and it failed where pure EPA succeeded4.

Comparison chart showing EPA is best for heart and mood, DHA is best for brain, and combined EPA plus DHA is best for inflammation

Four goals, four answers

Heart health: EPA, not both

A landmark trial gave 8,179 statin-treated patients pure EPA at 4 g/day. Major cardiovascular events dropped by 25%2. An earlier trial of 18,645 patients found that EPA at 1.8 g/day cut coronary events by 19%3.

A separate trial tested a mix of EPA and DHA together instead of pure EPA. No cardiovascular benefit4. Same class of fat, different result. A 2024 review confirmed that EPA and DHA have distinct effects on cardiovascular risk factors7. The key difference: only DHA raises LDL cholesterol1. One possible explanation is that the LDL-raising effect diluted EPA's benefit when they were combined.

For heart health, the molecule is EPA. Not a balanced blend.

Grade: A | Strong confidence

Two large trials (combined N over 26,000) show EPA alone reduces heart events. A mixed EPA+DHA trial showed no benefit, pointing to EPA as the active molecule for cardiovascular goals.

There's a debate about the landmark trial's placebo (mineral oil may have inflated the result slightly), but two independent trials reaching the same conclusion makes the signal reliable.

Mood and depression: EPA leads here too

Meta-analyses of omega-3 trials for depression reach the same conclusion: EPA-dominant formulas outperform DHA-dominant products for depressive symptoms5. The pattern holds across clinical depression, bipolar disorder, and peripartum populations.

The effective ratio in most mood studies is at least 60% EPA5. A standard 2:1 EPA:DHA supplement meets that. High-DHA products don't show the same antidepressant effect. If mood is your goal, check the label for the EPA number specifically.

Grade: A- | Strong confidence

Large meta-analyses find EPA-dominant formulas (60% EPA or more) outperform DHA-dominant products for depression. The effect is strongest as an add-on to antidepressant therapy.

Most studies tested clinical depression, not everyday low mood. The evidence for prevention in healthy people is thinner.

You just figured out which omega-3 fits your goal. Now find out if your bottle delivers it. Scan your bottle with Your Supp' Buddy and it'll check the EPA and DHA split against your goal and show you whether the dose matches what the evidence studied.

DHA for brain health: small but consistent

If you're under 50 and eat fish a couple of times a week, DHA supplements probably won't move the needle for you. The benefit is clearest in older adults and people who rarely eat fish.

A 2024 meta-analysis of 37 trials found DHA supplementation improved cognitive markers in older adults6. A dose-response review found that higher DHA levels in the body tracked with lower risk of cognitive decline13. The effect is strongest in people over 60 or anyone with low fish intake.

DHA supplementation is about protecting what you have, not a performance boost.

Grade: B | Moderate confidence

Multiple reviews show DHA improves memory and attention markers in older adults and people with low baseline DHA. The effect sizes are small to moderate.

Younger adults with adequate fish intake don't benefit much. This is maintenance, not enhancement.

Inflammation and recovery: both, together

For joint pain, exercise soreness, or general anti-inflammatory goals, EPA and DHA work as a team. EPA generates one family of inflammation-resolving molecules. DHA generates a different family11. Together they cover both pathways.

A 2026 meta-analysis of 41 trials found combined EPA+DHA at 2 g/day or more for at least six weeks reduced key inflammatory markers8. A separate review in rheumatoid arthritis confirmed reductions in inflammation and disease activity9.

Grade: A- | Strong confidence

Forty-one trials show drops in inflammatory markers (IL-6, TNF-alpha, muscle soreness) with combined EPA+DHA. Effects are clearest at 2 g/day or more for 6 weeks or longer.

CRP (the most commonly measured inflammatory marker) is more variable across studies. The effect on specific markers is more reliable than a blanket anti-inflammatory claim.

Not sure how your omega-3 fits with everything else you take? Show Your Supp' Buddy your full stack — scan each bottle and it'll check doses, flag interactions, and tell you if anything overlaps.

The dose your bottle probably isn't giving you

Finding the best omega-3 supplement for your goal means ignoring the big number on the front and going straight to the EPA and DHA breakdown on the back.

GoalWhat to takeDaily doseHow longEvidence
Heart healthEPA-only or EPA-dominant fish oil1.8 to 4 g EPAOngoingA
Mood / depressionEPA-dominant (EPA:DHA 2:1 or higher)1 to 2 g EPA8 to 16 weeks minimumA-
Brain / cognitionFish oil or algal oil (DHA-rich)500 mg to 1 g DHA6 to 24 monthsB
Inflammation / recoveryCombined EPA+DHA, TG form preferred2 to 3 g combined6 weeks minimumA-
General healthAny EPA+DHA supplement250 to 500 mg combinedOngoing

Form matters. At doses under 2 g/day, the natural triglyceride (TG) form works better than synthetic ethyl ester for lowering CRP10. Look for "triglyceride form" or "rTG" on the label. If it only says "fish oil concentrate" or "ethyl ester," it's the cheaper form.

Why most bottles use a 2:1 EPA:DHA ratio. Early omega-3 research focused on EPA, and the fish species used for most supplements naturally yield more EPA than DHA. That ratio works for inflammation and mood. It doesn't match the evidence for cardiovascular goals (pure EPA) or brain goals (DHA-dominant).

Vegan note. Algal oil covers DHA as well as fish oil. But most algal products contain little or no EPA. If you're plant-based and want EPA for heart or mood goals, you'll need a separate algae-sourced EPA supplement. Your body barely converts ALA from flaxseed and walnuts into EPA or DHA. Plant sources alone won't get you to therapeutic levels.

Safety and interactions

Omega-3 supplements have a strong safety record at standard doses. Two things to mention to your doctor:

Heart rhythm. In statin-treated patients with existing cardiovascular disease, 4 g/day of pure EPA added about 1 percentage point to the rate of atrial fibrillation hospitalizations (3.1% vs 2.1% on placebo)3. If you have a history of heart rhythm issues, talk to your cardiologist before starting high-dose omega-3.

Blood thinners. If you're on warfarin, aspirin, or other anticoagulants, let your prescriber know you're supplementing with omega-3. At high doses (4 g/day or more) it may increase bleeding time. At standard supplement doses (under 3 g/day), researchers checked whether combining omega-3 with statins caused problems. At standard doses, it didn't12.

Take omega-3 with food. Fat in the meal improves absorption.

The bottom line

The word "omega-3" has been doing a lot of marketing work for a long time. The trials that built the reputation weren't run on "omega-3." They were run on specific doses of EPA for cardiovascular risk, specific doses of DHA for brain maintenance, specific ratios for specific outcomes. The generic mixed blend that sits on every shelf matches almost none of those trials exactly.

A supplement industry built around a category will always produce products that average out the trials rather than replicate any of them. If you're actually chasing a result, don't buy the category. Buy the molecule the study used.

Get a personalised EPA vs DHA plan →

Opens Supp' Buddy on iOS or Android. Free to start. Tell it what you take and what you're after, and get back exactly where EPA vs DHA fits, or whether you can skip it entirely.

References

  1. Sacks FM, Lichtenstein AH (2022). Ethyl EPA and ethyl DHA cause similar and differential changes in plasma lipid concentrations. J Clin Lipidol. 16(6):887-894. PMID: 36522805
  2. Bhatt DL et al. / REDUCE-IT Investigators (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 380(1):11-22. PMID: 30415628
  3. Yokoyama M et al. / JELIS Investigators (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS). Lancet. 369(9567):1090-8. PMID: 17398308
  4. Nicholls SJ et al. (2021). Association Between Achieved Omega-3 Fatty Acid Levels and Major Adverse Cardiovascular Events (STRENGTH). JAMA. PMID: 33993205
  5. Omega-3 polyunsaturated fatty acids in depression (review) (2025). Curr Opin Clin Nutr Metab Care. 28(2):66-74. PMID: 39912390
  6. Liu X et al. (2024). Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults: A meta-analysis. Eur J Nutr. 63(4):1003-1022. PMID: 38300291
  7. Arnulfo et al. (2024). The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors. Front Nutr. 11:1423228. PMID: 39403396
  8. Li Z, Zhang B (2026). Effects of Omega-3 Supplementation on Inflammation and Recovery in Sports: A Meta-Analysis. FASEB J. 40(7):e71709. PMID: 41891174
  9. Chen D et al. (2024). Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: meta-analysis. Clin Rheumatol. 43(8):2479-2488. PMID: 38922552
  10. Blair C et al. (2026). Anti-inflammatory effects and safety of omega-3 fatty acids in haemodialysis: A systematic review and meta-analysis. Clin Nutr ESPEN. 72:102957. PMID: 41692069
  11. Serhan CN et al. (2024). Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation. FASEB J. 38(10):e23699. PMID: 38805158
  12. Pharmacokinetic comparison atorvastatin/omega-3 ethyl esters (2024). Drug Des Devel Ther. 18:395-406. PMID: 38352172
  13. Xiao Y et al. (2023). Fish intake, n-3 fatty acid body status, and risk of cognitive decline: systematic review and dose-response meta-analysis. Am J Clin Nutr. PMID: 34605891